ClinicalTrials.gg
CompletedNCT00037141Updated Oct 10, 2007

Safety/Tolerability Study of Alcohol Injection for Treatment of BPH (Enlarged Prostate)

A Phase 1/2 interventional study of dehydrated alcohol in Prostate Disease, BPH and Benign Prostatic Hyperplasia, sponsored by American Medical Systems. Completed. Open to male participants aged 50 Years to 80 Years. Per ClinicalTrials.gov, last updated 2007-10-10.

Primary conditionProstatic HyperplasiaRegistry: Prostatic DiseasesReclassifiedWhy we changed it
Registry
Prostatic Diseases — the first condition term the registry derived for this study.
ClinicalTrials.gg
Prostatic Hyperplasia
Why
  1. The study's listed conditions name Prostatic Hyperplasia, a narrower term within Prostatic Diseases.
Confidence
High: the new condition is named in the study's own listed conditions. Of 351 hand-checked studies reclassified this way, 68% were exactly right and 84% in the right disease family; the registry's first term was right for 5% (measured 2026-10-21). How we classify →
Wrong?
Tell us the study's main condition →

Sponsored by American Medical Systems · Phase 1/2, Interventional, and Treatment

Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →

Phase
Phase 1/2
Study type
Interventional
Enrollment
150
Allocation
Randomized
Ages
50 Years to 80 Years
Sex
Male
01

Study summary

Multi-center, prospective randomized dosing and safety research study. A maximum of 150 men will be enrolled in the study. Qualifying patients will receive one of three possible doses of the study drug. Symptoms will be evaluated before treatment, and then 1-week, 1-month, 3-months, and 6-months following treatment.

02

Conditions studied

  • Prostate Disease
  • BPH
  • Benign Prostatic Hyperplasia
  • Benign Prostatic Hypertrophy

Browse trials for

Keywords

  • Prostate
  • BPH
  • Prostatitis
03

In context

Prostatic Hyperplasia Reclassified

828 studies on the registry are indexed under Prostatic Hyperplasia; 179 are open to participants now.

This study's enrollment of 150 is above the median of 92 across 627 interventional studies indexed under Prostatic Hyperplasia.

Browse Prostatic Hyperplasia studies →

Lead sponsor

American Medical Systems is the lead sponsor of 9 studies on the registry; none are open to participants now.

Compared within Prostatic Hyperplasia, this study's primary condition as ClinicalTrials.gg classifies it; the registry's first condition term is Prostatic Diseases. The counts are of registry records indexed under each term, refreshed daily. How we classify →

04

Who can participate

Ages eligible
50 Years to 80 Years
Sexes eligible
Male
Accepts healthy volunteers
No

Eligibility criteria

Eligible patients are 50 to 80-year-old men who have experienced some or all of the following urinary symptoms for at least 6 months:

  • frequent or urgent need to urinate
  • difficulty starting their urinary stream
  • interruption of their urinary stream
  • feeling of incomplete emptying of bladder after urinating
  • interruption of sleep due to the urge to urinate

Patients should have tried oral medication for their condition in the past, and be willing to discontinue any current BPH medications for a period of time before undergoing study treatment. They should be in good general health and have no previous surgery, or other procedure(s) intended to reduce prostate size.

05

Study design

Phase
Phase 1 / Phase 2
Primary purpose
Treatment
Allocation
Randomized
Intervention model
Parallel assignment
Enrollment
150 participants

Interventions

06

Study locations

No study locations are listed for this record.

07

Timeline

Tracking since Sep 25, 2026
Not marked actual or estimatedDates not marked actual or estimated

The record gives a start of Mar 2002 and a completion of Mar 2004. It does not say whether these dates are actual or estimated.

How these figures are worked out, and which studies are left out of them.

Registered
May 15, 2002
First posted
May 17, 2002
Start
Mar 2002
Completion
Mar 2004
Last update
Oct 10, 2007
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
No changes since tracking began. The registry record was last updated on Oct 10, 2007, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
08

Registry details

Key details

Study ID
NCT00037141
Lead sponsor
American Medical Systems
First posted
May 17, 2002
Start date
Mar 2002
Completion
Mar 2004
Last update
Oct 10, 2007
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in Jun 2004. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Studies of the drug tested here: Ethanol

Start the discussion